| Year |
Title |
Altmetric |
| 2022
|
Diagnosis and Management of Bacterial Vaginosis: Summary of Evidence Reviewed for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines.
Clinical Infectious Diseases.
74:S144-S151.
2022
|
|
| 2022
|
Vaginal and Extra-Vaginal Bacterial Colonization and Risk for Incident Bacterial Vaginosis in a Population of Women Who Have Sex with Men.
Journal of Infectious Diseases.
225:1261-1265.
2022
|
|
| 2022
|
A qualitative exploration to understand barriers and facilitators to daily oral PrEP uptake and sustained adherence among HIV-negative women planning for or with pregnancy in rural Southwestern Uganda.
Journal of the International AIDS Society.
25.
2022
|
|
| 2022
|
Factors associated with syphilis seroprevalence in women with and at-risk for HIV infection in the Women's Interagency HIV Study (1994-2015).
Sexually Transmitted Infections.
98:4-10.
2022
|
|
| 2022
|
Prevalent human papillomavirus infection increases the risk of HIV acquisition in African women: advancing the argument for human papillomavirus immunization.
AIDS.
36:257-265.
2022
|
|
| 2022
|
PrEP service delivery preferences of black Cis-gender women living in the Southern United States.
AIDS and Behavior.
2022
|
|
| 2021
|
Differences in Vaginal Microbiota, Host Transcriptome, and Proteins in Women with Bacterial Vaginosis Are Associated with Metronidazole Treatment Response.
Journal of Infectious Diseases.
224:2094-2104.
2021
|
|
| 2021
|
Decreasing High-risk Exposures for Healthcare Workers through Universal Masking and Universal Severe Acute Respiratory Syndrome Coronavirus 2 Testing on Entry to a Tertiary Care Facility.
Clinical Infectious Diseases.
73:E3113-E3115.
2021
|
|
| 2021
|
Screening for Chlamydia and Gonorrhea
2021
|
|
| 2021
|
Molecular Characterization of Microbes in the Female Upper Genital Tract: A Valiant Quest to "redefine" Pelvic Inflammatory Disease.
Journal of Infectious Diseases.
224:S36-S38.
2021
|
|
| 2021
|
Cabotegravir for HIV prevention in cisgender men and transgender women.
New England Journal of Medicine.
385:595-608.
2021
|
|
| 2021
|
HIV and COVID-19: Lessons From HIV and STI Harm Reduction Strategies.
Current HIV/AIDS Reports.
18:261-270.
2021
|
|
| 2021
|
Impact of the menstrual cycle and ethinyl estradiol/etonogestrel contraceptive vaginal ring on granulysin and other mucosal immune mediators.
American Journal of Reproductive Immunology.
86.
2021
|
|
| 2021
|
Protection and risk: Male and female genital microbiota and sexually transmitted infections.
Journal of Infectious Diseases.
223:S222-S235.
2021
|
|
| 2021
|
Prevalence of and Factors Associated with Genital and Extragenital Chlamydia and Gonorrhea among Transgender Women in HIV Care in the United States, 2005 to 2016.
Sexually Transmitted Diseases.
48:410-416.
2021
|
|
| 2021
|
Missed Prevention Opportunities: Why Young, Black MSM with Recent HIV Diagnosis did not Access HIV Pre-exposure Prophylaxis Services.
AIDS and Behavior.
25:1464-1473.
2021
|
|
| 2021
|
Genetic variation in toll-like receptor 5 and colonization with flagellated bacterial vaginosis-associated bacteria.
Infection and Immunity.
89.
2021
|
|
| 2021
|
Influence of dapivirine vaginal ring use on cervicovaginal immunity and functional microbiome in adolescent girls.
AIDS.
35:369-380.
2021
|
|
| 2021
|
‘I still desire to have a child’: a qualitative analysis of intersectional HIV- and childlessness-related stigma in rural southwestern Uganda.
Culture, Health and Sexuality.
2021
|
|
| 2020
|
High rates of persistent and recurrent chlamydia in pregnant women after treatment with azithromycin
2020
|
|
| 2020
|
Intersecting Epidemics: Incident Syphilis and Drug Use in Women Living with Human Immunodeficiency Virus in the United States (2005-2016).
Clinical Infectious Diseases.
71:2405-2413.
2020
|
|
| 2020
|
Annals on call - diagnosing SARS-CoV-2 infection: Symptoms or no symptoms?.
Annals of Internal Medicine.
173.
2020
|
|
| 2020
|
Behavioral Counseling for Sexually Transmitted Infection Risk Reduction
2020
|
|
| 2020
|
Sexually Transmitted Infection Prevalence among Women at Risk for HIV Exposure Initiating Safer Conception Care in Rural, Southwestern Uganda.
Sexually Transmitted Diseases.
47:E24-E28.
2020
|
|
| 2020
|
Cervicitis: Balancing the Goals of Empiric Therapy and Antimicrobial Stewardship to Improve Women's Health.
Sexually Transmitted Diseases.
47:387-388.
2020
|
|
| 2020
|
Evaluation of the National Sexually Transmitted Disease Curriculum: Reach, Utilization, and Engagement.
Sexually Transmitted Diseases.
47:412-418.
2020
|
|
| 2020
|
Evaluation of the National Sexually Transmitted Disease Curriculum: Reach, Utilization, and Engagement..
Sexually Transmitted Diseases.
47:412-418.
2020
|
|
| 2020
|
Annals On Call - Protecting Health Care Workers From COVID-19.
Annals of Internal Medicine.
172:OC1.
2020
|
|
| 2020
|
Use of the dapivirine vaginal ring and effect on cervical cytology abnormalities.
AIDS.
34:559-567.
2020
|
|
| 2020
|
ECHO: context and limitations
2020
|
|
| 2019
|
Social harms in female-initiated HIV prevention method research: State of the evidence.
AIDS.
33:2237-2244.
2019
|
|
| 2019
|
Tenofovir disoproxil fumarate intravaginal ring for HIV pre-exposure prophylaxis in sexually active women: a phase 1, single-blind, randomised, controlled trial.
Lancet HIV.
6:e498-e508.
2019
|
|
| 2019
|
Recent Developments in Biomedical Issues in Sexually Transmitted Infections: Implications for Behavioral Parameters of Interest.
Sexually Transmitted Diseases.
46:E65-E67.
2019
|
|
| 2019
|
Tenofovir gel for prevention of herpes simplex virus type 2 acquisition: Findings from the VOICE trial.
Journal of Infectious Diseases.
219:1940-1947.
2019
|
|
| 2019
|
The Evolving Facets of Bacterial Vaginosis: Implications for HIV Transmission.
AIDS Research and Human Retroviruses.
35:219-228.
2019
|
|
| 2019
|
Safety and efficacy of a novel vaginal anti-infective, TOL-463, in the treatment of bacterial vaginosis and vulvovaginal candidiasis: A randomized, single-blind, phase 2, controlled trial.
Clinical Infectious Diseases.
68:803-809.
2019
|
|
| 2019
|
HIV status and other risk factors for prevalent and incident sexually transmitted infection during pregnancy (2000-2014)
2019
|
|
| 2018
|
Single-dose zoliflodacin (ETX0914) for treatment of urogenital gonorrhea.
New England Journal of Medicine.
379:1835-1845.
2018
|
|
| 2018
|
PrEParing Women to Prevent HIV: An Integrated Theoretical Framework to PrEP Black Women in the United States.
Journal of the Association of Nurses in AIDS Care.
29:835-848.
2018
|
|
| 2018
|
Sexually Transmitted Infection Prevalence in Women with HIV: Is There a Role for Targeted Screening?.
Sexually Transmitted Diseases.
45:762-769.
2018
|
|
| 2018
|
Health Care Provider Perceptions of a Sexually Transmitted Infection Self-testing Program in an HIV Care Clinic.
Sexually Transmitted Diseases.
45:417-421.
2018
|
|
| 2018
|
Clinical evaluation of the cepheid xpert tv assay for detection of trichomonas vaginalis with prospectively collected specimens from men and women.
Journal of Clinical Microbiology.
56.
2018
|
|
| 2018
|
BIOMEDICAL PREVENTION OF HIV IN WOMEN: CHALLENGES AND APPROACHES, WITH PARTICULAR REFERENCE TO THE VAGINAL MICROBIOME
2018
|
|
| 2018
|
Sexually transmitted infections in the era of antiretroviral-based HIV prevention: Priorities for discovery research, implementation science, and community involvement.
PLoS Medicine.
15.
2018
|
|
| 2017
|
The fourth generation AlereTM HIV Combo rapid test improves detection of acute infection in MTN-003 (VOICE) samples.
Journal of Clinical Virology.
94:15-21.
2017
|
|
| 2017
|
Differences in Cumulative Exposure and Adherence to Tenofovir in the VOICE, iPrEx OLE, and PrEP Demo Studies as Determined via Hair Concentrations.
AIDS Research and Human Retroviruses.
33:778-783.
2017
|
|
| 2017
|
HIVR4P 2016, Partnering for Prevention: Conference Summary and Highlights.
AIDS Research and Human Retroviruses.
33:749-759.
2017
|
|
| 2017
|
Sexually transmitted infections: challenges ahead.
Lancet Infectious Diseases.
17:e235-e279.
2017
|
|
| 2017
|
Contraceptive Use and Pregnancy Incidence among Women Participating in an HIV Prevention Trial.
Journal of Women's Health.
26:670-676.
2017
|
|
| 2017
|
Prevention of Sexually Transmitted Diseases in HIV-Infected Individuals.
Current HIV/AIDS Reports.
14:41-46.
2017
|
|
| 2017
|
Validity of self-reported history of Chlamydia trachomatis infection.
American Journal of Obstetrics and Gynecology.
216:393.e1-393.e7.
2017
|
|
| 2017
|
Clinical performance of the Solana® Point-of-Care Trichomonas Assay from clinician-collected vaginal swabs and urine specimens from symptomatic and asymptomatic women
2017
|
|
| 2017
|
Risk Factors for Incidence of Sexually Transmitted Infections among Women in a Human Immunodeficiency Virus Chemoprevention Trial: VOICE (MTN-003).
Sexually Transmitted Diseases.
44:135-140.
2017
|
|
| 2017
|
Diversity in the US Infectious Diseases Workforce: Challenges for Women and Underrepresented Minorities.
Journal of Infectious Diseases.
216:S606-S610.
2017
|
|
| 2016
|
A conversation among the IAS–USA board of directors: Hot topics and emerging data in HIV research and care.
Topics in antiviral medicine.
24:142-151.
2016
|
|
| 2016
|
A conversation among the IAS–USA board of directors: Hot topics and emerging data in HIV research and care.
Topics in antiviral medicine.
24:142-151.
2016
|
|
| 2016
|
HIV prevention: Opportunities and challenges.
Topics in antiviral medicine.
24:123-126.
2016
|
|
| 2016
|
HIV prevention: Opportunities and challenges.
Topics in antiviral medicine.
24:123-126.
2016
|
|
| 2016
|
Ocular Syphilis: a Clinical Review.
Current Infectious Disease Reports.
18.
2016
|
|
| 2016
|
Reporting of Adherence in the VOICE Trial: Did Disclosure of Product Nonuse Increase at the Termination Visit?.
AIDS and Behavior.
20:2654-2661.
2016
|
|
| 2016
|
More Easily Cultivated Than Identified: Classical Isolation with Molecular Identification of Vaginal Bacteria.
Journal of Infectious Diseases.
214:S21-S28.
2016
|
|
| 2016
|
The Vaginal Microbiome: Current Understanding and Future Directions.
Journal of Infectious Diseases.
214:S36-S41.
2016
|
|
| 2016
|
Variations in Clinical Presentation of Ocular Syphilis: Case Series Reported from a Growing Epidemic in the United States.
Sexually Transmitted Diseases.
43:519-523.
2016
|
|
| 2016
|
An Empiric HIV Risk Scoring Tool to Predict HIV-1 Acquisition in African Women
2016
|
|
| 2016
|
Antiretroviral Therapy for Prevention of Human Immunodeficiency Virus Infection.
Medical Clinics of North America.
100:927-950.
2016
|
|
| 2016
|
Rapid Diagnosis of Trichomonas vaginalis by Testing Vaginal Swabs in an Isothermal Helicase-Dependent AmpliVue Assay.
Sexually Transmitted Diseases.
43:369-373.
2016
|
|
| 2016
|
Divergent adherence estimates with pharmacokinetic and behavioural measures in the MTN-003 (VOICE) study.
Journal of the International AIDS Society.
19.
2016
|
|
| 2016
|
Pharmacological measures of treatment adherence and risk of HIV infection in the VOICE study.
Journal of Infectious Diseases.
213:335-342.
2016
|
|
| 2016
|
Bone mineral density changes among young, healthy African women receiving oral tenofovir for HIV preexposure prophylaxis
2016
|
|
| 2015
|
Oral and vaginal tenofovir for genital herpes simplex virus type 2 shedding in immunocompetent women: A double-blind, randomized, cross-over trial.
Journal of Infectious Diseases.
212:1949-1956.
2015
|
|
| 2015
|
Factors associated with bone mineral density in healthy African women.
Archives of Osteoporosis.
10.
2015
|
|
| 2015
|
A Shot in the Arm for HIV Prevention? Recent Successes and Critical Thresholds.
AIDS Research and Human Retroviruses.
31:1055-1059.
2015
|
|
| 2015
|
Disclosure of pharmacokinetic drug results to understand nonadherence.
AIDS.
29:2161-2171.
2015
|
|
| 2015
|
Barriers to bacterial sexually transmitted infection testing of HIV-infected men who have sex with men engaged in HIV primary care.
Sexually Transmitted Diseases.
42:590-594.
2015
|
|
| 2015
|
Levels of Genital Tract Defensins and Cytokines Differ between HIV-Uninfected US and African Women.
American Journal of Reproductive Immunology.
74:313-322.
2015
|
|
| 2015
|
Soluble Immune Mediators and Vaginal Bacteria Impact Innate Genital Mucosal Antimicrobial Activity in Young Women.
American Journal of Reproductive Immunology.
74:323-332.
2015
|
|
| 2015
|
Relationship of specific bacteria in the cervical and vaginal microbiotas with cervicitis.
Sexually Transmitted Diseases.
42:475-481.
2015
|
|
| 2015
|
Interpretation, communication, and mechanisms of associations between injectable contraception and HIV risk - Authors' reply..
Lancet HIV.
2:e366-e367.
2015
|
|
| 2015
|
Rapid and profound shifts in the vaginal microbiota following antibiotic treatment for bacterial vaginosis.
Journal of Infectious Diseases.
212:793-802.
2015
|
|
| 2015
|
Syphilis? An Unusual Cause of Surgical Emergency in a Human Immunodeficiency Virus-Infected Man..
Open Forum Infectious Diseases.
2:ofv094.
2015
|
|
| 2015
|
Advancing care for lesbian, gay, bisexual, and transgender persons: Enough already?.
Annals of Internal Medicine.
163:143-144.
2015
|
|
| 2015
|
Tenofovir-based preexposure prophylaxis for HIV infection among African women.
Obstetrical and Gynecological Survey.
70:444-446.
2015
|
|
| 2015
|
A phase 3, multicenter, randomized, double-blind, vehicle-controlled study evaluating the safety and efficacy of metronidazole vaginal gel 1.3% in the treatment of bacterial vaginosis.
Sexually Transmitted Diseases.
42:376-381.
2015
|
|
| 2015
|
Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: A prospective cohort study.
Lancet HIV.
2:e279-e287.
2015
|
|
| 2015
|
Women who have sex with women living in low- and middle-income countries: A systematic review of sexual health and risk behaviors.
LGBT Health.
2:91-104.
2015
|
|
| 2015
|
Perceptions and Experiences with the VOICE Adherence Strengthening Program (VASP) in the MTN-003 Trial.
AIDS and Behavior.
19:770-783.
2015
|
|
| 2015
|
Metabolic signatures of bacterial vaginosis.
mBio.
6.
2015
|
|
| 2015
|
Tenofovir-based preexposure prophylaxis for HIV infection among African women.
New England Journal of Medicine.
372:509-518.
2015
|
|
| 2015
|
What's new in sexually transmitted infections in the hiv care setting: Focus on syphilis and gonorrhea.
Topics in antiviral medicine.
22:698-701.
2015
|
|
| 2014
|
Recent advances in understanding and managing Chlamydia trachomatis infections.
F1000prime reports.
6.
2014
|
|
| 2014
|
Review: Self-collected samples are less accurate for HPV testing than cliniciancollected samples.
Annals of Internal Medicine.
161.
2014
|
|
| 2014
|
HIV prevention in clinical care settings: 2014 Recommendations of the International Antiviral Society-USA Panel
2014
|
|
| 2014
|
Antiviral activity of genital tract secretions after oral or topical tenofovir pre-exposure prophylaxis for HIV-1
2014
|
|
| 2014
|
Addressing standards of care in resource-limited settings
2014
|
|
| 2014
|
Bacterial Vaginosis and the Cervicovaginal Immune Response.
American Journal of Reproductive Immunology.
71:555-563.
2014
|
|
| 2014
|
Changes in vaginal bacterial concentrations with intravaginal metronidazole therapy for bacterial vaginosis as assessed by quantitative PCR (Journal of Clinical Microbiology (2009) 47, 3, (721-726)).
Journal of Clinical Microbiology.
52:3137.
2014
|
|
| 2014
|
Improving HIV/STD prevention in the care of persons living with HIV through a national training program.
AIDS Patient Care and STDS.
28:15-21.
2014
|
|
| 2013
|
Bacterial vaginosis-associated bacteria in men: Association of Leptotrichia/Sneathia spp. with nongonococcal urethritis.
Sexually Transmitted Diseases.
40:944-949.
2013
|
|
| 2013
|
Introduction to the special issue highlighting Anaerobe 2012.
Anaerobe.
24:85-86.
2013
|
|
| 2013
|
Screening and management of genital chlamydial infections.
Infectious Disease Clinics of North America.
27:739-753.
2013
|
|
| 2013
|
More Than Meets the Eye: Associations of Vaginal Bacteria with Gram Stain Morphotypes Using Molecular Phylogenetic Analysis.
PLoS ONE.
8.
2013
|
|
| 2013
|
Population-Level Benefits from Providing Effective HIV Prevention Means to Pregnant Women in High Prevalence Settings.
PLoS ONE.
8.
2013
|
|
| 2013
|
A prospective cohort study comparing the effect of single-dose 2 G metronidazole on trichomonas vaginalis infection in HIV-seropositive versus HIV-seronegative women.
Sexually Transmitted Diseases.
40:499-505.
2013
|
|
| 2013
|
Performance of the cepheid CT/NG Xpert rapid PCR test for detection of Chlamydia trachomatis and Neisseria gonorrhoeae.
Journal of Clinical Microbiology.
51:1666-1672.
2013
|
|
| 2013
|
Vaginal biofilms and bacterial vaginosis: Of mice and women.
Journal of Infectious Diseases.
207:1481-1483.
2013
|
|
| 2013
|
American sexually transmitted diseases association and the thomas parran award: Past, present, and future.
Sexually Transmitted Diseases.
40:275-276.
2013
|
|
| 2013
|
Editorial Commentary: Sexual networks, sex hormones, and recurrent bacterial vaginosis: Not such strange bedfellows.
Clinical Infectious Diseases.
56:787-879.
2013
|
|
| 2013
|
Sexually transmitted infections.
Infectious Disease Clinics of North America.
27:9-10.
2013
|
|
| 2012
|
Mucosal escherichia coli bactericidal activity and immune mediators are associated with HIV-1 seroconversion in women participating in the HPTN 035 trial.
Journal of Infectious Diseases.
206:1931-1935.
2012
|
|
| 2012
|
Behavioral predictors of colonization with lactobacillus crispatus or Lactobacillus jensenii after treatment for bacterial vaginosis: A cohort study
2012
|
|
| 2012
|
Bacterial communities in women with bacterial vaginosis: High resolution phylogenetic analyses reveal relationships of microbiota to clinical criteria.
PLoS ONE.
7.
2012
|
|
| 2012
|
Extravaginal reservoirs of vaginal bacteria as risk factors for incident bacterial vaginosis.
Journal of Infectious Diseases.
205:1580-1588.
2012
|
|
| 2012
|
The posttrial effect of oral periodic presumptive treatment for vaginal infections on the incidence of bacterial vaginosis and lactobacillus colonization.
Sexually Transmitted Diseases.
39:361-365.
2012
|
|
| 2012
|
Emerging sexual health issues among women who have sex with women.
Current Infectious Disease Reports.
14:204-211.
2012
|
|
| 2012
|
Chlamydia positivity in women screened in family planning clinics: Racial/ethnic differences and trends in the Northwest U.S., 1997-2006.
Public Health Reports.
127:38-51.
2012
|
|
| 2011
|
Interventions to prevent sexually transmitted infections, including HIV infection.
Clinical Infectious Diseases.
53.
2011
|
|
| 2011
|
Sexually transmitted infections among women who have sex with women.
Clinical Infectious Diseases.
53.
2011
|
|
| 2011
|
Effect of sexual activity on vaginal colonization with hydrogen peroxide-producing lactobacilli and gardnerella vaginalis.
Sexually Transmitted Diseases.
38:1137-1144.
2011
|
|
| 2011
|
Performance of swabs, lavage, and diluents to quantify biomarkers of female genital tract soluble mucosal mediators.
PLoS ONE.
6.
2011
|
|
| 2011
|
A behavioural intervention to reduce persistence of bacterial vaginosis among women who report sex with women: Results of a randomised trial.
Sexually Transmitted Infections.
87:399-405.
2011
|
|
| 2011
|
Interpreting the epidemiology and natural history of bacterial vaginosis: Are we still confused?.
Anaerobe.
17:186-190.
2011
|
|
| 2011
|
Establishing and sustaining a healthy vaginal environment: Analysis of data from a randomized trial of periodic presumptive treatment for vaginal infections.
Journal of Infectious Diseases.
204:323-326.
2011
|
|
| 2011
|
Chlamydia trachomatis infection among women reporting sexual activity with women screened in family planning clinics in the Pacific Northwest, 1997 to 2005.
American Journal of Public Health.
101:1284-1290.
2011
|
|
| 2010
|
Bacterial vaginosis: Identifying research gaps proceedings of a workshop sponsored by DHHS/NIH/NIAID.
Sexually Transmitted Diseases.
37:732-744.
2010
|
|
| 2010
|
Antiretroviral-based HIV prevention strategies for women.
Expert Review of Anti-infective Therapy.
8:1177-1186.
2010
|
|
| 2010
|
Temporal variability of human vaginal bacteria and relationship with bacterial vaginosis.
PLoS ONE.
5.
2010
|
|
| 2010
|
Risks for acquisition of Bacterial vaginosis among women who report sex with women: A cohort study.
PLoS ONE.
5.
2010
|
|
| 2010
|
Even NHANES evolves: Some surprising findings about women who have sex with women.
Sexually Transmitted Diseases.
37:414-415.
2010
|
|
| 2010
|
Prevalence and risks for bacterial vaginosis in women who have sex with women.
Sexually Transmitted Diseases.
37:335-339.
2010
|
|
| 2010
|
Walter E. Stamm, MD, 1945-2009.
Sexually Transmitted Diseases.
37:281-282.
2010
|
|
| 2009
|
Preferred characteristics of vaginal microbicides in women with bacterial vaginosis.
Journal of Women's Health.
18:1163-1167.
2009
|
|
| 2009
|
Changes in vaginal bacterial concentrations with intravaginal metronidazole therapy for bacterial vaginosis as assessed by quantitative PCR.
Journal of Clinical Microbiology.
47:721-726.
2009
|
|
| 2009
|
Distribution of genital Lactobacillus strains shared by female sex partners.
Journal of Infectious Diseases.
199:680-683.
2009
|
|
| 2009
|
Sexually transmitted infections and associated conditions among women who have sex with women.
Open Infectious Diseases Journal.
3:128-134.
2009
|
|
| 2008
|
Chlamydia positivity in american Indian/Alaska native women screened in family planning clinics, 1997-2004.
Sexually Transmitted Diseases.
35:753-757.
2008
|
|
| 2008
|
Diversity of human vaginal bacterial communities and associations with clinically defined bacterial vaginosis.
Applied and Environmental Microbiology.
74:4898-4909.
2008
|
|
| 2008
|
Routine HIV testing in the context of syndromic management of sexually transmitted infections: Outcomes of the first phase of a training programme in Botswana.
Sexually Transmitted Infections.
84:259-264.
2008
|
|
| 2008
|
Relationship of specific vaginal bacteria and bacterial vaginosis treatment failure in women who have sex with women.
Annals of Internal Medicine.
149.
2008
|
|
| 2008
|
Hormonal contraceptive use modulates the local inflammatory response to bacterial vaginosis.
Sexually Transmitted Infections.
84:57-61.
2008
|
|
| 2008
|
Acceptability of urine-based screening for Chlamydia trachomatis in asymptomatic young men: a systematic review..
Sexually Transmitted Diseases.
35.
2008
|
|
| 2008
|
The cost-effectiveness of screening men for Chlamydia trachomatis: a review of the literature..
Sexually Transmitted Diseases.
35.
2008
|
|
| 2008
|
The program cost and cost-effectiveness of screening men for Chlamydia to prevent pelvic inflammatory disease in women..
Sexually Transmitted Diseases.
35.
2008
|
|
| 2007
|
Emerging issues in management of sexually transmitted diseases in HIV infection.
Current Infectious Disease Reports.
9:518-530.
2007
|
|
| 2007
|
Population-based outreach for chlamydia screening in men: Results from a randomized trial.
Sexually Transmitted Diseases.
34:837-839.
2007
|
|
| 2007
|
Expanding the spectrum of pathogens in urethritis: Implications for presumptive therapy?.
Clinical Infectious Diseases.
45:872-874.
2007
|
|
| 2007
|
Elusive aetiology of bacterial vaginosis. Do lesbians have a clue?.
Sexually Transmitted Infections.
83:424-425.
2007
|
|
| 2007
|
Targeted PCR for detection of vaginal bacteria associated with bacterial vaginosis.
Journal of Clinical Microbiology.
45:3270-3276.
2007
|
|
| 2007
|
Within the hidden epidemic: Sexually transmitted diseases and HIV/AIDS among American Indians and Alaska natives.
Sexually Transmitted Diseases.
34:767-777.
2007
|
|
| 2007
|
Selective testing criteria for gonorrhea among young women screened for chlamydial infection: Contribution of race and geographic prevalence.
Journal of Infectious Diseases.
196:731-737.
2007
|
|
| 2007
|
Effectiveness of two tinidazole regimens in treatment of bacterial vaginosis: A randomized controlled trial.
Obstetrics and Gynecology.
110:302-309.
2007
|
|
| 2007
|
Management of women with cervicitis.
Clinical Infectious Diseases.
44.
2007
|
|
| 2007
|
Acceptability of urine-based screening for Chlamydia trachomatis to asymptomatic young men and their providers.
Sexually Transmitted Diseases.
34:147-153.
2007
|
|
| 2007
|
Superficial hepatic capsular lesions in a systemically ill young woman.
Sexually Transmitted Diseases.
34:139-140.
2007
|
|
| 2007
|
Correlates of sexually transmitted infections in young women [1].
Journal of Infectious Diseases.
195:303.
2007
|
|
| 2007
|
Syphilis and other sexually transmitted diseases in HIV infection.
2007
|
|
| 2006
|
Reply to Forney et al. [4].
Journal of Infectious Diseases.
194:1469-1470.
2006
|
|
| 2006
|
Women's satisfaction with an intravaginal Lactobacillus capsule for the treatment of bacterial vaginosis.
Journal of Women's Health.
15:1053-1060.
2006
|
|
| 2006
|
A persistent(ly) enigmatic ecological mystery: Bacterial vaginosis.
Journal of Infectious Diseases.
193:1475-1477.
2006
|
|
| 2006
|
Prevalence of Neisseria gonorrhoeae among men screened for Chlamydia trachomatis in four United States Cities, 1999-2003.
Sexually Transmitted Diseases.
33:314-319.
2006
|
|
| 2006
|
Risk factors for cervicitis among women with bacterial vaginosis.
Journal of Infectious Diseases.
193:617-624.
2006
|
|
| 2006
|
Chlamydial infections among female adolescents screened in juvenile detention centers in Washington State, 1998-2002.
Sexually Transmitted Diseases.
33:63-67.
2006
|
|
| 2006
|
The authors reply [2].
New England Journal of Medicine.
354:202-203.
2006
|
|
| 2005
|
Molecular identification of bacteria associated with bacterial vaginosis.
New England Journal of Medicine.
353:1899-1911.
2005
|
|
| 2005
|
Cervical specimen order and performance measures of Chlamydia trachomatis diagnostic testing.
Journal of Clinical Microbiology.
43:5295-5297.
2005
|
|
| 2005
|
Dangerous assumptions: Lesbians and sexual death.
Sexually Transmitted Diseases.
32:570-571.
2005
|
|
| 2005
|
Sexual practices, risk perception and knowledge of sexually transmitted disease risk among lesbian and bisexual women.
Perspectives on Sexual and Reproductive Health.
37:6-12.
2005
|
|
| 2005
|
Impact of patient characteristics on performance of nucleic acid amplification tests and DNA probe for detection of Chlamydia trachomatis in women with genital infections.
Journal of Clinical Microbiology.
43:577-584.
2005
|
|
| 2005
|
Prevalence of Chlamydia trachomatis infection among men screened in 4 U.S. cities.
Sexually Transmitted Diseases.
32:74-77.
2005
|
|
| 2005
|
Molecular methodology in determining vaginal flora in health and disease: Its time has come.
Current Infectious Disease Reports.
7:463-470.
2005
|
|
| 2005
|
Mucopurulent cervicitis: No longer ignored, but still misunderstood.
Infectious Disease Clinics of North America.
19:333-349.
2005
|
|
| 2005
|
Sexual tourism: Implications for travelers and the destination culture.
Infectious Disease Clinics of North America.
19:103-120.
2005
|
|
| 2004
|
Barriers to infectious disease care among lesbians..
Emerging Infectious Diseases.
10:1974-1978.
2004
|
|
| 2004
|
Re-evaluating Selective Screening Criteria for Chlamydial Infection among Women in the U.S. Pacific Northwest.
Sexually Transmitted Diseases.
31:283-289.
2004
|
|
| 2004
|
Evolving issues in understanding and treating bacterial vaginosis.
Expert Review of Anti-infective Therapy.
2:913-922.
2004
|
|
| 2004
|
Lesbian Health Matters: A Pap Test Education Campaign Nearly Thwarted by Discrimination.
Health Promotion Practice.
5:314-325.
2004
|
|
| 2004
|
Reproductive health history of lesbians: Implications for care.
American Journal of Obstetrics and Gynecology.
190:1298-1304.
2004
|
|
| 2004
|
Sexually transmitted diseases in the HIV care setting: what's really going on down there?
2004
|
|
| 2003
|
Prevalence and Risk Factors for Infection with Herpes Simplex Virus Type-1 and -2 among Lesbians.
Sexually Transmitted Diseases.
30:890-895.
2003
|
|
| 2003
|
Functional characterization of class Ia- and non-class Ia-restricted Chlamydia-reactive CD8+ T cell responses in humans.
Journal of Immunology.
171:4278-4286.
2003
|
|
| 2003
|
Vulvovaginal candidiasis
2003
|
|
| 2003
|
Common complementary and alternative therapies for yeast vaginitis and bacterial vaginosis: A systematic review.
Obstetrical and Gynecological Survey.
58:351-358.
2003
|
|
| 2003
|
The clinical and economic consequences of screening young men for genital chlamydial infection.
Sexually Transmitted Diseases.
30:99-106.
2003
|
|
| 2003
|
Candidiasis (vulvovaginal).
2003
|
|
| 2003
|
Chlamydia trachomatis infection in asymptomatic men.
American Journal of Preventive Medicine.
24:36-42.
2003
|
|
| 2002
|
Head-to-head multicenter comparison of DNA probe and nucleic acid amplification tests for Chlamydia trachomatis infection in women performed with an improved reference standard.
Journal of Clinical Microbiology.
40:3757-3763.
2002
|
|
| 2002
|
Extracts from "Concise Clinical Evidence": Vulvovaginal candidiasis
2002
|
|
| 2002
|
Predicting chlamydial and gonococcal cervical infection: Implications for management of cervicitis.
Obstetrics and Gynecology.
100:579-584.
2002
|
|
| 2002
|
Characterization of vaginal flora and bacterial vaginosis in women who have sex with women.
Journal of Infectious Diseases.
185:1307-1313.
2002
|
|
| 2002
|
Vulvovaginal candidiasis.
2002
|
|
| 2002
|
Vulvovaginal candidiasis.
2002
|
|
| 2001
|
Erratum: The relative increase in prevalence using LCR was highest among men with < 5 polymorphonuclear leukocytes per high-power (1000×) field (PMN/HPF) on urethral Gram stain regardless of symptoms, and in symptomatic men with gonorrhea diagnosed by urethral culture (Sexually Transmitted Diseases 28:4 (220)).
Sexually Transmitted Diseases.
28:429.
2001
|
|
| 2001
|
Impact of New Sexually Transmitted Disease Diagnostics on Clinical Practice and Public Health Policy..
Current Infectious Disease Reports.
3:147-151.
2001
|
|
| 2001
|
Characteristics of female sexually transmitted disease clinic clients who report same-sex behaviour.
International Journal of STD and AIDS.
12:41-46.
2001
|
|
| 2001
|
Papanicolaou test screening and prevalence of genital human papillomavirus among women who have sex with women.
American Journal of Public Health.
91:947-952.
2001
|
|
| 2001
|
Urine-based screening for Chlamydia trachomatis in men attending sexually transmitted disease clinics.
Sexually Transmitted Diseases.
28:219-225.
2001
|
|
| 2000
|
Sexually transmitted infections in women who have sex with women: Who cares?.
Sexually Transmitted Infections.
76:330-332.
2000
|
|
| 2000
|
Genital human papillomavirus infection in women who have sex with women: A concern for patients and providers.
AIDS Patient Care and STDS.
14:447-451.
2000
|
|
| 2000
|
Genital human papillomavirus infection in women who have sex with women: A review.
American Journal of Obstetrics and Gynecology.
183:770-774.
2000
|
|
| 1998
|
Genital human papillomavirus infection in women who have sex with women.
Journal of Infectious Diseases.
178:1604-1609.
1998
|
|
| 1998
|
New approaches to the diagnosis, treatment, and prevention of chlamydial infection.
Current Clinical Topics in Infectious Diseases.
37-59.
1998
|
|
| 1997
|
Community-based urine screening for Chlamydia trachomatis with a ligase chain reaction assay.
Annals of Internal Medicine.
127:796-803.
1997
|
|
| 1997
|
Selective screening for chlamydial infection in women: A comparison of three sets of criteria.
Perspectives on Sexual and Reproductive Health.
29:158-162.
1997
|
|
| 1997
|
Selective screening for chlamydial infection in women: A comparison of three sets of criteria.
Perspectives on Sexual and Reproductive Health.
29:158-162.
1997
|
|
| 1997
|
Cesarean delivery in women with genital herpes in washington state, 1989-1991.
1997
|
|
| 1997
|
Performance and cost-effectiveness of selective screening criteria for Chlamydia trachomatis infection in women: Implications for a national chlamydia control strategy.
Sexually Transmitted Diseases.
24:131-141.
1997
|
|
| 1995
|
Chancroid: new developments in an old disease..
Current Clinical Topics in Infectious Diseases.
15:129-152.
1995
|
|
